These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8217800)

  • 1. Influence of demographic factors on antithrombin III activity in a healthy population.
    Tait RC; Walker ID; Islam SI; McCall F; Conkie JA; Mitchell R; Davidson JF
    Br J Haematol; 1993 Jul; 84(3):476-80. PubMed ID: 8217800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein C activity in healthy volunteers--influence of age, sex, smoking and oral contraceptives.
    Tait RC; Walker ID; Islam SI; McCall F; Conkie JA; Wight M; Mitchell R; Davidson JF
    Thromb Haemost; 1993 Aug; 70(2):281-5. PubMed ID: 8236135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin III and procoagulant activity: sex differences and effects of the menopause.
    Meade TW; Dyer S; Howarth DJ; Imeson JD; Stirling Y
    Br J Haematol; 1990 Jan; 74(1):77-81. PubMed ID: 2310699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral contraceptive agents and antithrombin III].
    Kamenov V; Nalbanski B
    Akush Ginekol (Sofiia); 1990; 29(1):60-3. PubMed ID: 1695492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antithrombin III: reference values found with a chromogenic substrate (chromozym TH) (author's transl)].
    Hesse R; Tritschler W; Castelfranchi G; Bablok W
    Blut; 1981 Apr; 42(4):227-34. PubMed ID: 7225580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of hormone replacement therapy on antithrombin III and protein C levels in menopausal women.
    Lacroix KA; Bean C; Reilly R; Curran-Celentano J
    Clin Lab Sci; 1997; 10(3):145-8. PubMed ID: 10167774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen levels in healthy volunteers--influence of age, sex, smoking and oral contraceptives.
    Tait RC; Walker ID; Conkie JA; Islam SI; McCall F; Mitchell R; Davidson JF
    Thromb Haemost; 1992 Nov; 68(5):506-10. PubMed ID: 1455395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein C, antithrombin III and plasminogen: effect of age, sex and blood group.
    Dolan G; Neal K; Cooper P; Brown P; Preston FE
    Br J Haematol; 1994 Apr; 86(4):798-803. PubMed ID: 7918075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
    Al-Farra HM; Al-Fahoum SK; Tabbaa MA
    Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma fibrinogen in women: relationships with oral contraception, the menopause and hormone replacement therapy.
    Lee AJ; Lowe GD; Smith WC; Tunstall-Pedoe H
    Br J Haematol; 1993 Apr; 83(4):616-21. PubMed ID: 8518178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epidemiological study of the haemostatic and other effects of oral contraceptives.
    Meade TW; Brozović M; Chakrabarth R; Howarth DJ; North WR; Stirling Y
    Br J Haematol; 1976 Nov; 34(3):353-64. PubMed ID: 990177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III, heparin cofactor and antifactor Xa in relation to age, sex and pathological condition.
    Panicucci F; Sagripanti A; Conte B; Pinori E; Vispi M; Lecchini L
    Haemostasis; 1980; 9(5):297-302. PubMed ID: 7409613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
    Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total cholinesterase in plasma: biological variations and reference limits.
    Lepage L; Schiele F; Gueguen R; Siest G
    Clin Chem; 1985 Apr; 31(4):546-50. PubMed ID: 3978785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
    Nash AL; Cornish EJ; Hain R
    Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral contraceptives on antithrombin III measurement.
    Petersen C; Kelly R; Minard B; Cawley LP
    Am J Clin Pathol; 1979 Jul; 72(1):134-5. PubMed ID: 453106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III and platelets during the normal menstrual cycle and in women receiving oral contraceptives low in oestrogen.
    Jespersen J; Ingeberg S; Bach E
    Gynecol Obstet Invest; 1983; 15(3):153-62. PubMed ID: 6832651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation factors and antithrombin levels in young and elderly subjects in Pakistani population.
    Amin H; Mohsin S; Aslam M; Hussain S; Saeed T; Ullah MI; Sami W
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):745-50. PubMed ID: 23135380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardiovascular risk factors.
    Giansante C; Fiotti N; Cattin L; Da Col PG; Calabrese S
    Thromb Haemost; 1994 May; 71(5):581-6. PubMed ID: 8091384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.